当前位置: X-MOL 学术Haematologica › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase 3, placebocontrolled QUAZAR AML-001 trial.
Haematologica ( IF 10.1 ) Pub Date : 2021-09-23 , DOI: 10.3324/haematol.2021.279174
Gail J Roboz 1 , Hartmut Döhner 2 , Christopher Pocock 3 , Herve Dombret 4 , Farhad Ravandi 5 , Jun Ho Jang 6 , Dominik Selleslag 7 , Jiři Mayer 8 , Uwe M Martens 9 , Jane Liesveld 10 , Teresa Bernal 11 , Ming Chung Wang 12 , Peiwen Yu 13 , Ling Shi 13 , Shien Guo 13 , Ignazia La Torre 14 , Barry Skikne 15 , Qian Dong 16 , Julia Braverman 16 , Salem Abi Nehme 14 , C L Beach 16 , Andrew H Wei 17
Affiliation  

Not available.

中文翻译:

口服阿扎胞苷为缓解期急性髓性白血病患者保持良好的疲劳水平和与健康相关的生活质量:来自 3 期安慰剂对照 QUAZAR AML-001 试验的结果。

无法使用。
更新日期:2021-09-23
down
wechat
bug